Cannabis, marijuana and Hemp stock news from Investorideas.com plus daily cannabis #potcasts - Investor Ideas #Potcasts #Cannabis News and Stocks on the Move
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSXV: $OGI.V) (OTCQX: $OGRMF), (CSE: $MW.C) (OTC: $MICWF), (TSXV: $META.V), (TSXV: $PURE.V) (OTC: $PRCNF) and (TSXV: $OGO.V)
Delta, Kelowna, BC - January 16, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Good afternoon and welcome to another Investorideas.com "potcast", looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Organigram Holdings Inc., the parent company of Organigram Inc., a leading licensed producer of cannabis has partnered with Canada's Smartest Kitchen (CSK), a leader in food product development, to expand the Company's ongoing research and development related to edible cannabis products. Following the legalization of adult use recreational cannabis in Canada in 2018, cannabis edibles are expected to be legalized later in 2019 with the draft amendments to The Cannabis Act for edibles having been issued by the Federal Government for public consultation on December 20, 2018. Organigram's initial strategic product development work with CSK will focus on the chocolate confectionery market.
"Our collaboration with Canada's Smartest Kitchen is an example of, and a next step in, the outstanding strategic partnerships Organigram has developed to support the growth of its recreational product offering and business overall," says Ray Gracewood, Chief Commercial Officer, Organigram.
Since 2016, Organigram has leveraged its relationship with TGS International, LLC ("TGS") to better understand product trends within regulated U.S. markets, as well as gain a deep understanding of technology, process and product development through TGS's specialization in the extract market.
"As the recreational cannabis industry in Canada anticipates the pending legalization of cannabis edibles, we are excited to combine the technology and product trending understanding we now have through our relationship with TGS with the experience of Canada's Smartest Kitchen to develop a signature line of products that delivers the exceptional quality, flavours and forms that adult Canadians are looking for."
Micron Waste Technologies Inc., a leading developer of waste treatment systems for food and cannabis waste, announced the appointment of Alfred Wong to President and Chief Executive Officer, effective immediately. Mr. Wong succeeds CEO Rav Mlait.
"Alfred joined Micron as President in 2016 and has been instrumental in overseeing the development of the Company's research and development from design to prototype," said Kal Malhi, Chairman. "In his new role as President and CEO, he will oversee strategic growth initiatives with a focus on accelerating commercialization of our food and cannabis waste processing systems. He will also lead expansion into new product verticals for industries such as food processing, brewing and spirits, pulp and paper and biological pharmaceuticals."
Micron's food and Cannavore™ cannabis waste treatment systems are industrial-grade organic waste processers which pulverize and render organic waste in combination with a proprietary blend of microbes and enzymes designed and developed by Micron. Importantly, as part of Micron's full-system waste treatment platform, effluent from the systems is further treated to derive clean greywater which can be reused in industrial or agricultural operation. Alternatively, the regulatory-compliant greywater, which meets municipal discharge standards, can be safely discharged. Active pharmaceutical ingredients (APIs) in cannabis waste are denatured, preventing bio-accumulation in watersheds.
National Access Cannabis Corp. announced that its wholly owned subsidiary, NAC Prairies Ltd., has entered into a share purchase agreement in respect of an arm's length transaction with the shareholders of New Leaf Emporium Inc., whereby NAC Prairies will acquire all of the issued and outstanding shares of New Leaf Emporium. Under the terms of the share purchase agreement, the total purchase price payable for the New Leaf Emporium Shares is $1.6 million, comprised of a cash payment of $1.2 million from NAC Prairies and the issuance of 649,880 common shares of NAC, which have an aggregate dollar value of approximately $400,000. Additionally, NAC Prairies will reimburse New Leaf Emporium for certain expenses associated with the build out of the Moose Jaw premises on standard commercial terms. The Purchase Price and New Leaf Emporium Shares have been placed into escrow and will be released to the respective parties upon the Saskatchewan Liquor and Gaming Authority providing NAC with approval to operate the New Leaf Emporium premises in Moose Jaw, Saskatchewan, following which NAC Prairies will own all of the issued and outstanding shares of New Leaf Emporium.
"We're growing our footprint into Saskatchewan," said Mark Goliger, CEO of NAC. "We've worked diligently to be the national leader in cannabis retail, having opened 21 stores to date in the complex regulatory markets of Alberta and Manitoba, and with our experience, Saskatchewan is an ideal expansion market for NAC. We have what's required: great relationships with Licensed Producers, existing e-commerce infrastructure, and retail operator know-how. Moose Jaw is the right market to start, with the New Leaf Emporium store operational today as one of only 2 stores serving a population of 35,000. We're ready to lead the way for customers in three provinces through a proven model of safety, education and customer service while delivering sustained returns and increased growth for our shareholders."
Pure Global Cannabis Inc. an integrated, growth-oriented life sciences and consumer products cannabis company, through its subsidiary PureSinse Inc., announced the launch of the Clinical Cannabinoid Education Network, CCEN.ca, a not-for-profit, to educate and inform physicians about the latest breakthroughs related to medical cannabis.
The Clinical Cannabinoid Education Network (CCEN) provides an educational platform for medical practitioners who want to learn more about the science of cannabis and its place in their clinical practice. By providing education and a forum for physicians by physicians, they can share new information and learn from one another in a supportive environment. This will allow more patients to obtain the latest and most effective treatments as determined by their doctors, including safe access to medical cannabis.
Run jointly as a partnership initiative between Spark Cannabis and PureSinse, the CCEN launch features an initial networking dinner on January 31, 2019 and a full summit on May 10, 2019.
Organto Foods Inc. today announced that the Organto Global Cannabis Group, through its wholly-owned subsidiary, Medicannabis S.A.S., has been granted a license from Colombia's Ministry of Justice to cultivate non-psychoactive cannabis (CBD) at its cultivation and breeding facility in Guasca, Cundinamarca, Colombia. The license authorizes the cultivation of non-psychoactive cannabis in Colombia for medicinal use and further processing into cannabis products, including but not limited to, oils, tinctures, beverages, topicals and other products. It also allows for grain and seed production and for scientific purposes.
"We are thrilled to receive this license as was anticipated, and as a result we now have the ability to advance the breeding and seed production of high-CBD cannabis cultivars adapted for equatorial climates." commented Todd Dalotto, President of the Organto Global Cannabis Group. "The granting of this license is a key first step as we establish our low-cost, ecologically designed growing and processing facilities and build out our commercial operations using cultivars developed from our diverse seed library."
Organto acquired 100% of Medicannabis, a late stage applicant for licenses to enable it to cultivate and process medicinal cannabis in Colombia, in November 2018. The acquisition was part of Organto's strategy to build out a global cannabis group using cost-effective M&A strategies. The acquisition of a late stage applicant came with certain uncertainties and risks, many of which have now been mitigated with the grant of this license, supporting Organto's cost-effective approach to the transaction.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
#Cannabis #Stock News Alert: Pure Global Cannabis (TSX.V: $PURE.V) (OTC: $PRCNF) Announces Health Canada Sales License, @pureglobalcanna
TORONTO - January 16, 2019 (Investorideas.com Newswire) Cannabis stock news alert Pure Global Cannabis Inc. (TSX.V:PURE) (OTC: PRCNF) (FRA:1QS) an integrated, growth-oriented life sciences and consumer products cannabis company, through its subsidiary PureSinse Inc. ("PureSinse"), reports that Health Canada has issued PureSinse a Sales License under the Cannabis Act.
Eligible and pre-registered Canadian medical patients can soon select from two dozen premium cannabis products offered by PureSinse, via its newly launched eCommerce website at PureSinse.com. The Company is committed to supporting medical cannabis patients by emphasizing the quality of and access to the products they need. The Company anticipates growing to 70 SKUs (stock-keeping units) by mid-2019, including adding extracted oil products, and vape pens.
PureSinse continues to demonstrate commitment to the medical community by leading one of the largest real-world evidence-based clinical studies in conjunction with the Appletree Medical Group and one of the largest Clinical Research Organizations in the world. The clinical data, which will be collected from thousands of patients, will provide necessary data points for guidance in the therapeutic benefits of specific cannabis strains for commonly reported medical symptoms. This evidence will guide PureSinse's future pharmaceutical product and consumer product development plans and provide the medical community with published peer reviewed observational data on the efficacy of medical cannabis for a range of conditions.
As part of the Sales Licence, the Company can also sell products into the adult-legal consumer market through provincially licensed retailers, for which it is launching uniquely curated lines of consumer products tailored to specific market segments.
"This is a significant milestone for us and something we have been vigorously preparing for over the last several months," said Malay Panchal, CEO of Pure Global. "We feel the medical community has been hugely underserviced with poor patient and physician education, and product offerings, areas we hope to be trail blazers in and make a significant contribution to in 2019," added Mr. Panchal.
About Pure Global Cannabis
Pure Global Cannabis Inc. (TSX.V:PURE; OTC:PRCNF; FRA:1QS) is an innovation-based cannabis Company led by experienced pharma, biotechnology, horticultural, and consumer packaged goods (CPG) experts. The Company's wholly owned subsidiary, PureSinse Inc., is a licensed producer under the Cannabis Act. The Company's Brampton campus houses facilities for vertically farmed cultivation, R&D, extraction, manufacturing, and distribution. PURE will produce branded and white-labeled cannabis products for the medical, pharmaceutical, wellness, health & beauty, natural health, food & beverage, and recreational legal markets with uniquely formulated and purified concentrates. The Company is using the Canadian market as a springboard to develop and manufacture GMP-compliant cannabis products for international sale and distribution with a goal to become one of the most trusted premium international cannabis brands.
To register to Pure Global's mailing list, please visit www.pureglobal.com. Follow @pureglobalcanna on Twitter and Facebook and @pureglobalcannabis on Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains certain forward-looking statements, including, but not limited to, statements about Pure Global's future plans and intentions. Wherever possible, words such as "may", "will", "should", "could", "expect", "plan", "intend", "anticipate", "believe", "estimate", "predict" or "potential" or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect management's current beliefs and are based on information currently available to management as at the date hereof.
Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, Pure Global cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and Pure Global assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
To register to Pure Global's mailing list, please visit www.pureglobal.com . Follow @pureglobalcanna on Twitter and Facebook and @pureglobalcannabis on Instagram.
SOURCE Pure Global Cannabis Inc.
Disclosure: Investorideas. does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: the publishing of this news release is a paid for service ( Third party ). Learn more about costs and our services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSX V: $OGI.V) (CSE: $FONE.C) (CSE: $DOSE.C) (CSE: $AUSA.C) (CSE: $BE.C) (OTCQX: $BLEVF) (CSE: $MTEC.C)
Delta, Kelowna, BC - January 15, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Good afternoon and welcome to another Investorideas.com "potcast", looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today we will be looking at announcements from Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), Flower One Holdings Inc. (CSE: FONE) (OTCQB: FLOOF), Rapid Dose Therapeutics Inc. (CSE: DOSE), Australis Capital Inc. (CSE: AUSA), Beleave Inc. (CSE: BE) (OTCQX: BLEVF) and Cannvas MedTech Inc. (CSE: MTEC) (OTCPK: CANVF).
Organigram Holdings Inc., the parent company of Organigram Inc., a leading licensed producer of cannabis announced it is the first in the Canadian cannabis industry to introduce Integra Boost packaging technology into its entire line of dry flower products from 1g to 15g to help maintain freshness, extend shelf life and enhance the overall customer experience.
"At Organigram, we are exceptionally proud of the quality of our products," says Ray Gracewood, Chief Commercial Officer, Organigram. "At every step, we look for ways to ensure our products reflect the very best that science and technology have to offer. Now, we can extend that commitment to our product even after it leaves our facility. The Integra Boost technology helps us ensure our customers always receive product that is fresh."
Integra Boost packs have accompanied Organigram's Edison Reserve line of premium cannabis products since the Edison launch in 2018. "Uncompromised quality is a hallmark of the Edison Reserve brand and we've seen first hand the outstanding benefits that come with pairing our commitment to excellence with the Integra Boost technology," explains Gracewood. "We are pleased to now be able to extend that optimal experience of freshness to all Edison products, even after purchase."
Integra Boost packs comprise a glycerin gel and 2-way membrane to create a patented humidity control technology, either releasing or absorbing moisture as needed to ensure the optimal environment for storing cannabis. Long used to help protect, for example, the freshness of food and pharmaceuticals, the technology maintains relative humidity at 62 per cent in a contained environment. This consistency helps preserve the product's color, taste, structural integrity and weight.
Flower One Holdings Inc. announced its first brand partnership for cannabis product fulfillment in Nevada. Flower One and Rapid Dose Therapeutics Inc. entered into a definitive agreement on January 10, 2019, pursuant to which Flower One has been granted license to manufacture, distribute and sell RDT's QuickStrip™, an innovative, proprietary delivery technology for the cannabis market in Nevada.
Flower One expects to produce and distribute QuickStrip™ for the medical and adult recreational cannabis market in Nevada by Spring 2019. RDT's proprietary QuickStrip™ technology is a Quick, Convenient, Precise, Discreet™ oral fast-dissolving drug delivery system. The QuickStrip™ technology offers consumers a discreet and smoke-free alternative to enjoy cannabis.
"Brand partnerships are a key component to Flower One's growth strategy in the Nevada cannabis market," said Ken Villazor, Flower One's President and CEO. "Our cultivation, processing and custom packaging facilities in Nevada will total more than 480,000 square feet. The scale, technology and automation of our facilities will bring precision, quality and a consistent ability for Flower One to bring RDT's innovative QuickStrip™ delivery technology to Nevada's fast-growing cannabis market."
Nevada is one of the most lucrative cannabis markets in the United States, hosting more than 55 million tourists annually from all over the globe to Las Vegas - an audience of almost 1.5 times greater than the population of Canada. The state reported $529.9 million in sales for all 2018 marijuana sales - that includes recreational, medicinal and cannabis-related products.
"Through our Managed Strip Service (MSS), RDT is focused and committed to providing consumers in the United States cannabis markets a Smoke-Free Choice." said Mark Upsdell, CEO of RDT. "RDT's Gold Vendor Status agreement with Flower One will enable them to sell to all the legal dispensaries in Nevada, under both their own private brand and as a white label program to the other licensed growers in Nevada. Our brand partnership with Flower One further strengthens and positions QuickStrip™ for rapid growth as an international brand and delivery device to cannabis consumers - while delivering health and improving outcomes." Villazor adds, "With QuickStrip™'s discreet and measured dosing, we are well positioned to bring a unique and exciting product offering to Las Vegas and Nevada's tourist-driven cannabis market, and we are thrilled to be adding it to Flower One's portfolio of Brand Partners."
Australis Capital Inc. announced that the Company has invested $3,000,000 USD in Folium Biosciences, the largest vertically integrated producer, manufacturer, and distributor of hemp derived phytocannabinoids in the United States. Folium also owns and operates the largest phytocannabinoid extraction and purification facility in the United States, with plans for a new pharmaceutical division and the completion of their Canadian facility in 2019.
"With the passing of the 2018 Farm Bill and the floodgates opening for this vibrant and exciting industry, we are poised for strong growth this year," said Kashif Shan, CEO of Folium. "As a global industry leader and authority in PCR hemp oil extraction and product development, we welcome Australis' participation in this private placement as we continue to pave the way and dominate the marketplace."
Supplying the market with its own unique 0.0% THC phytocannabinoid-rich hemp oil, Folium is a global leader in non-psychoactive cannabinoids. Folium's chromatographic purification process selectively removes the psychoactive component from the phytocannabinoid-rich hemp oil. Folium is certified by the Colorado Department of Public Health and Environment as a producer of 0.0% THC products, including CBD hemp oil, CBD gel caps, water soluble CBD, Cannabidiol HYDROPCR, CBD e-liquid, CBD concentrates, CBD for pets, CBD salves and balms, CBD tinctures, CBD face masks, and white-label CBD products.
"Our strategic investment in Folium Biosciences provides Australis and our brands access to the leading player in the fast-evolving United States CBD market," said Scott Dowty, CEO of Australis. "Folium's breadth of expertise, spanning production, extraction, branding and commercialization, will greatly benefit Australis as we introduce and expand our CBD product offerings in the United States in the months and years ahead."
Beleave Inc. announced that its wholly-owned subsidiary Beleave Kannabis Corp. has been authorized by Health Canada to sell cannabis oil products effective January 11, 2019. After reviewing the application and supporting documentation, Health Canada granted an amended licence with modified conditions allowing for the sale of cannabis oil under the Cannabis Regulations.
"This license is pivotal to us meeting our goals in 2019, while driving product innovation and augmenting our research and development initiatives," said Roger Ferreira, Ph.D., Beleave's Chief Science Officer. "Oils will continue to make up a larger part of the cannabis market, especially as we ramp up for the regulatory changes coming in 2019. Receiving our sales authorization allows us to provide a wider array of products while providing Beleave with higher margins than dried flower."
Cannvas MedTech Inc., a leading digital cannabis educator and business technology company, and Cannametrics, a collaborative crowd-sourced data science project to classify the effects of cannabis strains and products, announced the signing of definitive joint marketing agreement to explore, in good faith, collaborative opportunities to share insights into data metrics across the Canadian cannabis landscape through their respective Cannvas.Me and Cannametrics.io platforms.
"We are thrilled to be in active talks with Eric and Gina at Cannametrics to discover how our organizations can pool resources to paint a better picture of cannabis consumption across Canada through our accessible and evidence-backed Cannvas.Me cannabis education resource and the innovative Cannametrics platform," said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. "Cannametrics recognizes the value of data and data analysis in surveying cannabis usage among Canadians and we hope to work together to leverage that knowledge with supporting statistics from our Cannvas.Me digital cannabis learning platform to inform the decisions of policymakers, producers and retailers in shaping how cannabis is legislated, distributed and used from coast to coast."
Much like the Cannvas.Me platform strives to inform users of the potential health benefits of cannabis and educate them on whether it fits with their lifestyle, Cannametrics is poised to be an industry disrupter by acknowledging people respond differently to cannabis products and providing personalized recommendations through its advanced machine-learning backend. Developed by Eric Jacobsen, MFC, and Dr. Gina Conte, Ph.D., to address the pressing concern of credibility in the marketplace, Cannametrics' goal is to arm cannabis consumers with a collaborative crowd-sourced tool to track the experiential effects of different cannabis strains and products and streamline their cannabis experience.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
#Cannabisstocks: Pure Global Cannabis (TSX.V: $PURE.V) (OTC: $PRCNF) Awarded Health Canada Sales License
TORONTO - January 15, 2019 (Investorideas.com Newswire) Pure Global Cannabis Inc. (TSX.V:PURE) (OTC: PRCNF) ( FRA:1QS) an integrated, growth-oriented life sciences and consumer products cannabis company, through its subsidiary PureSinse Inc. ("PureSinse"), reports that Health Canada has issued PureSinse a Sales License under the Cannabis Act.
Eligible and pre-registered Canadian medical patients can soon select from two dozen premium cannabis products offered by PureSinse, via its newly launched eCommerce website at PureSinse.com. The Company is committed to supporting medical cannabis patients by emphasizing the quality of and access to the products they need. The Company anticipates growing to 70 SKUs (stock-keeping units) by mid-2019, including adding extracted oil products, and vape pens.
PureSinse continues to demonstrate commitment to the medical community by leading one of the largest real-world evidence-based clinical studies in conjunction with the Appletree Medical Group and one of the largest Clinical Research Organizations in the world. The clinical data, which will be collected from thousands of patients, will provide necessary data points for guidance in the therapeutic benefits of specific cannabis strains for commonly reported medical symptoms. This evidence will guide PureSinse's future pharmaceutical product and consumer product development plans and provide the medical community with published peer reviewed observational data on the efficacy of medical cannabis for a range of conditions.
As part of the Sales Licence, the Company can also sell products into the adult-legal consumer market through provincially licensed retailers, for which it is launching uniquely curated lines of consumer products tailored to specific market segments.
"This is a significant milestone for us and something we have been vigorously preparing for over the last several months," said Malay Panchal, CEO of Pure Global. "We feel the medical community has been hugely underserviced with poor patient and physician education, and product offerings, areas we hope to be trail blazers in and make a significant contribution to in 2019," added Mr. Panchal.
About Pure Global Cannabis
Pure Global Cannabis Inc. (TSX.V:PURE; OTC:PRCNF; FRA:1QS) is an innovation-based cannabis Company led by experienced pharma, biotechnology, horticultural, and consumer packaged goods (CPG) experts. The Company's wholly owned subsidiary, PureSinse Inc., is a licensed producer under the Cannabis Act. The Company's Brampton campus houses facilities for vertically farmed cultivation, R&D, extraction, manufacturing, and distribution. PURE will produce branded and white-labeled cannabis products for the medical, pharmaceutical, wellness, health & beauty, natural health, food & beverage, and recreational legal markets with uniquely formulated and purified concentrates. The Company is using the Canadian market as a springboard to develop and manufacture GMP-compliant cannabis products for international sale and distribution with a goal to become one of the most trusted premium international cannabis brands.
To register to Pure Global's mailing list, please visit www.pureglobal.com. Follow @pureglobalcanna on Twitter and Facebook and @pureglobalcannabis on Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains certain forward-looking statements, including, but not limited to, statements about Pure Global's future plans and intentions. Wherever possible, words such as "may", "will", "should", "could", "expect", "plan", "intend", "anticipate", "believe", "estimate", "predict" or "potential" or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect management's current beliefs and are based on information currently available to management as at the date hereof.
Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, Pure Global cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and Pure Global assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
To register to Pure Global's mailing list, please visit www.pureglobal.com . Follow @pureglobalcanna on Twitter and Facebook and @pureglobalcannabis on Instagram.
SOURCE Pure Global Cannabis Inc.
Disclosure: Investorideas. does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: the publishing of this news release is a paid for service ( Third party ). Learn more about costs and our services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
